Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Work In Process (2017 - 2025)

Historic Work In Process for Dexcom (DXCM) over the last 13 years, with Q4 2025 value amounting to $105.0 million.

  • Dexcom's Work In Process rose 27366.55% to $105.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $105.0 million, marking a year-over-year increase of 27366.55%. This contributed to the annual value of $105.0 million for FY2025, which is 27366.55% up from last year.
  • According to the latest figures from Q4 2025, Dexcom's Work In Process is $105.0 million, which was up 27366.55% from $78.6 million recorded in Q3 2025.
  • Dexcom's 5-year Work In Process high stood at $105.0 million for Q4 2025, and its period low was $13.6 million during Q2 2021.
  • Moreover, its 5-year median value for Work In Process was $29.0 million (2023), whereas its average is $40.3 million.
  • In the last 5 years, Dexcom's Work In Process tumbled by 1297.47% in 2023 and then skyrocketed by 27366.55% in 2025.
  • Quarter analysis of 5 years shows Dexcom's Work In Process stood at $16.2 million in 2021, then increased by 6.17% to $17.2 million in 2022, then surged by 74.42% to $30.0 million in 2023, then fell by 6.33% to $28.1 million in 2024, then skyrocketed by 273.67% to $105.0 million in 2025.
  • Its Work In Process stands at $105.0 million for Q4 2025, versus $78.6 million for Q3 2025 and $94.0 million for Q2 2025.